Literature DB >> 26518045

Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling.

Yonatan H Grad1, Edward Goldstein2, Marc Lipsitch3, Peter J White4.   

Abstract

The rise in gonococcal antibiotic resistance and the threat of untreatable infection are focusing attention on strategies to limit the spread of drug-resistant gonorrhea. Mathematical models provide a framework to link the natural history of infection and patient behavior to epidemiological outcomes and can be used to guide research and enhance the public health impact of interventions. While limited knowledge of key disease parameters and networks of spread has impeded development of operational models of gonococcal transmission, new tools in gonococcal surveillance may provide useful data to aid tracking and modeling. Here, we highlight critical questions in the management of gonorrhea that can be addressed by mathematical models and identify key data needs. Our overarching aim is to articulate a shared agenda across gonococcus-related fields from microbiology to epidemiology that will catalyze a comprehensive evidence-based clinical and public health strategy for management of gonococcal infections and antimicrobial resistance.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Neisseria gonorrhoeae; antibiotic resistance; gonorrhea; immunity; mathematical modeling; sexually transmitted infections; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26518045      PMCID: PMC4760416          DOI: 10.1093/infdis/jiv517

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

Review 1.  Design and interpretation of vaccine field studies.

Authors:  M E Halloran; I M Longini; C J Struchiner
Journal:  Epidemiol Rev       Date:  1999       Impact factor: 6.222

2.  Dynamics and control of the transmission of gonorrhea.

Authors:  J A Yorke; H W Hethcote; A Nold
Journal:  Sex Transm Dis       Date:  1978 Apr-Jun       Impact factor: 2.830

3.  Evaluating treatment protocols to prevent antibiotic resistance.

Authors:  S Bonhoeffer; M Lipsitch; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  The role of sexual partnership networks in the epidemiology of gonorrhea.

Authors:  A C Ghani; J Swinton; G P Garnett
Journal:  Sex Transm Dis       Date:  1997-01       Impact factor: 2.830

5.  Epidemiological models for sexually transmitted diseases.

Authors:  K Dietz; K P Hadeler
Journal:  J Math Biol       Date:  1988       Impact factor: 2.259

6.  The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey.

Authors:  G P Garnett; K J Mertz; L Finelli; W C Levine; M E St Louis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

7.  Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.

Authors:  Charlotte K Kent; Janice K Chaw; William Wong; Sally Liska; Steven Gibson; Gregory Hubbard; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

8.  Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations.

Authors:  M Kretzschmar; Y T van Duynhoven; A J Severijnen
Journal:  Am J Epidemiol       Date:  1996-08-01       Impact factor: 4.897

9.  Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations.

Authors:  G P Garnett; R M Anderson
Journal:  IMA J Math Appl Med Biol       Date:  1994

10.  Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example.

Authors:  Peter J White; Helen Ward; Jackie A Cassell; Catherine H Mercer; Geoff P Garnett
Journal:  J Infect Dis       Date:  2005-07-21       Impact factor: 5.226

View more
  21 in total

1.  Testing for gonorrhoea should routinely include the pharynx.

Authors:  Lilith K Whittles; Xavier Didelot; Yonatan H Grad; Peter J White
Journal:  Lancet Infect Dis       Date:  2018-07       Impact factor: 25.071

Review 2.  The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.

Authors:  Daniel H F Rubin; Jonathan D C Ross; Yonatan H Grad
Journal:  Transl Res       Date:  2020-02-29       Impact factor: 7.012

3.  Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.

Authors:  Lilith K Whittles; Xavier Didelot; Peter J White
Journal:  Lancet Infect Dis       Date:  2022-04-12       Impact factor: 71.421

4.  Genomic Analysis and Comparison of Two Gonorrhea Outbreaks.

Authors:  Xavier Didelot; Janina Dordel; Lilith K Whittles; Caitlin Collins; Nicole Bilek; Cynthia J Bishop; Peter J White; David M Aanensen; Julian Parkhill; Stephen D Bentley; Brian G Spratt; Simon R Harris
Journal:  mBio       Date:  2016-06-28       Impact factor: 7.867

5.  Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model.

Authors:  Ruthie Birger; John Saunders; Claudia Estcourt; Andrew John Sutton; Catherine H Mercer; Tracy Roberts; Peter J White
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

6.  Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study.

Authors:  Stephanie M Fingerhuth; Nicola Low; Sebastian Bonhoeffer; Christian L Althaus
Journal:  BMC Med       Date:  2017-07-26       Impact factor: 8.775

7.  Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established.

Authors:  Joanna Lewis; Malcolm J Price; Paddy J Horner; Peter J White
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

8.  Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study.

Authors:  Katy Me Turner; Hannah Christensen; Elisabeth J Adams; David McAdams; Helen Fifer; Anthony McDonnell; Neil Woodford
Journal:  BMJ Open       Date:  2017-06-14       Impact factor: 2.692

9.  Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.

Authors:  Lilith K Whittles; Peter J White; Xavier Didelot
Journal:  PLoS Med       Date:  2017-10-31       Impact factor: 11.069

10.  Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners.

Authors:  Stephanie M Fingerhuth; Sebastian Bonhoeffer; Nicola Low; Christian L Althaus
Journal:  PLoS Pathog       Date:  2016-05-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.